强力益气颗粒对H2O2损伤大鼠L6骨骼肌成肌细胞的作用及机制研究OA
Study on the effects and mechanisms of Qiangli Yiqi Granules on H2O2-injured L6 skeletal muscle myoblasts in rats
目的 通过观察强力益气颗粒对H2O2 损伤大鼠L6 骨骼肌成肌细胞的作用,探讨骨骼肌糖代谢信号途径中介复合体 13/核受体 4 家族成员 2/葡萄糖转运蛋白-4(mediator complex 13/nuclear receptor family 4 member-2/glucose transporter-4,MED13/Nurr1/GLUT-4)在重症肌无力中的可能的作用机制.方法 将鼠L6 骨骼肌成肌细胞分离培育好后,分为正常血清组、模型组、空白血清组和强力益气含药血清高、中、低剂量组共6 组.除正常血清组外,其余各组均使用H2O2 造成氧化损伤,正常血清组与模型组分别换液加入FBS完全培养基培育;空白血清组换液加入正常大鼠血清培育(排除PBS对细胞的影响),强力益气含药血清高、中、低剂量组分别换液加入相应剂量组的大鼠含药血清培育,培养24 小时后收集细胞.应用细胞增殖检测、流式凋亡周期检测;分别应用Real-time PCR、免疫荧光、Western blot 检测法,检测强力益气血清对 L6 骨骼肌成肌细 PGC-1α、MEF2、MED13、Nurr1、GLUT-4 蛋白质定量、定位、定性的表达.结果 H2O2 处理2 小时对L6 大鼠肌细胞的增殖有显著的抑制作用(P<0.05),凋亡率显著上升(P<0.05),强力益气颗粒含药血清能够提高H2O2 损伤大鼠L6 骨骼肌成肌细胞的增殖率,降低凋亡率.能使MED13 基因在转录水平、基因在蛋白水平上出现明显的上调(P<0.05);对于Nurr1 基因则是相对模型组降低了其转录水平(P<0.05);对于PGC-1α、MEF2 以及GLUT-4,H2O2 处理都显著降低了它们的转录水平(P<0.05),含药血清的预处理能够一定程度上逆转这种降低(P<0.05),同时呈现出一定程度上的剂量依赖性.结论 强力益气颗粒含药血清通过提高MED13、GLUT-4、PGC-1α、MEF2 基因蛋白水平的表达,并且降低Nurr1 基因蛋白水平的表达,对H2O2 损伤大鼠L6 骨骼肌成肌细胞具有保护作用,从而得出强力益气颗粒含药血清通过干预MED13/Nurr1/GLUT4 信号通路,能改善骨骼肌糖代谢,减少骨骼肌细胞损伤,进而改善重症肌无力骨骼肌功能受损的病理状态.
Objective By observing the effect of Qiangli Yiqi Granule on myoblasts of L6 skeletal muscle in rats injured by H2O2,the possible mechanism of action of MED 13/Nurr1/GLUT-4,a member of nuclear receptor 4 family,in MG was discussed.Methods After the L6 skeletal muscle myoblasts were isolated and cultured,they were divided into six groups:the normal serum group,the model group,the blank serum group,and the high,medium and low dose groups of serum containing Qiangyiqi Granule.Except for the normal serum group,all the other groups used H2O2 to cause oxidative damage.The normal serum group and the model group were cultured in FBS complete medium respectively.The blank serum group was incubated with normal rat serum(excluding the influence of PBS on cells),while the high,the medium and the low dose groups of Qiangyiqi medicated serum were incubated with rat medicated serum in corresponding dose groups,and the cells were collected after 24 hours of culture.Cell proliferation and apoptosis cycle were detected.Real-time PCR,immunofluorescence and Western blot were used to detect the quantitative,localized and qualitative expressions of Qiangli Yiqi serum on L6 skeletal muscle myofibrils PGC-1α,MEF2,MED13,Nurr1 and GLUT-4 protein.Results H2O2 treatment for 2 hours of the proliferation of myoblasts was significantly inhibited in L6 rats(P<0.05),and the apoptosis rate was significantly increased(P<0.05).The medicated serum of Qiangli Yiqi Granule can improve the proliferation rate of myoblasts in L6 skeletal muscles of rats injured by H2O2 and reduce the transfer to green.MED13 gene was significantly up-regulated at transcription level and protein level(P<0.05).Compared with the model group,the transcription level of Nurr1 gene was decreased(P<0.05).For PGC-1α,MEF2 and GLUT-4,H2O2 treatment significantly reduced their transcription levels(P<0.05),and pretreatment of drug-containing serum could reverse this extent(P<0.05),and at the same time a certain dose dependence was showed.Conclusion The medicated serum of Qiangli Yiqi Granule has a protective effect on L6 skeletal muscle myoblasts injured by H2O2 by increasing the protein levels of MED13,GLUT-4,PGC-1α,MEF2,and decreasing the protein level of Nurr1.It is concluded that the medicated serum of Qiangli Yiqi Granule can improve the glucose metabolism of skeletal muscle,reduce the damage of skeletal muscle cells,and further improve the pathology of impaired function of MG skeletal muscle by interfering with MED13/Nurr1/GLUT4 signaling pathway.
陈建;李慧凛;应汝炯;董云;沈洁;吴丽琳;盛昭园
200082 上海中医药大学附属上海市中西结合医院重症肌无力传统医学科上海市浦东新区公利医院肾内科200082 上海中医药大学附属上海市中西结合医院重症肌无力传统医学科200082 上海中医药大学附属上海市中西结合医院重症肌无力传统医学科200082 上海中医药大学附属上海市中西结合医院重症肌无力传统医学科200082 上海中医药大学附属上海市中西结合医院重症肌无力传统医学科200082 上海中医药大学附属上海市中西结合医院重症肌无力传统医学科
医药卫生
重症肌无力大鼠L6骨骼肌成肌细胞强力益气颗粒骨骼肌糖代谢中介复合体13/核受体4家族成员2/葡萄糖转运蛋白-4信号途径
myasthenia gravisrat L6 skeletal muscle myoblastsQiangli Yiqi Granulesskeletal muscle glucose metabolismMediator complex 13/nuclear receptor 4 family member 2/glucose transporter-4 signaling pathway
《环球中医药》 2026 (1)
27-35,9
上海市卫生健康委员会"海派中医流派传承延伸计划"(ZY(2021-2023)-0209-07)"十四五"中医特色专科建设(肌病专科)(ZYTSZK2-5)虹口区第二轮"国医强优"三年行动计划(2022-2024年)(HKGYQYXM-2022-15)上海市虹口区卫生健康委员会中医药科研课题(HKQGYQY-ZYY-2023-05,HKQGYQY-ZYY-2023-04)上海中医药大学第二十四期课程建设项目上海中医药大学2022年度应对奥密克戎感染新型冠状病毒肺炎应急攻关项目(2022YJ-44)上海中医药大学科技发展基金项目资助(23KFL087)
评论